Morningstar, Inc. (MORN)

Nasdaq Financials Financial Exchanges & Data S&P MidCap 400
$244.15
-3.02 (-1.22%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+7.9%
1M+20.4%
3M+21.4%
6M+38.2%
YTD+12.3%
1Y+14.9%
3Y-5.1%
5Y-22.9%

Key statistics

Full financials →
Market cap$9.1B
P/E (TTM)21.4
EPS (TTM, diluted)$11.41
P/S3.46
P/B8.83
EV / EBITDA12.1
Revenue (TTM)$2.62B
Revenue growth+9.4%
Net margin17.0%
ROE43.4%
Debt / equity1.65
FCF yield5.4%
Dividend yield0.61%
Payout ratio13%
Beta (1Y)0.00
Volatility (1Y)41.7%
52-week range$141.49 – $248.88
Avg volume (50D)285.49K

Revenue & net income — last 8 quarters

Statements →
Oct 28, 4:37 PM ET

Morningstar Q3 revenue rises 8.9% to $672.1 million; diluted EPS up 41.0% to $3.06

Positive earnings 2.027.01

Morningstar reported third-quarter 2026 results on October 28, 2026. Revenue rose 8.9% to $672.1 million and GAAP diluted earnings per share rose 41.0% to $3.06, while free cash flow fell 2.9% to $155.4 million. The company repurchased $100.0 million of its shares in the quarter, and its debt was $1.7 billion as of September 30, 2026, up from $1.1 billion at December 31, 2025.

  • Revenue of $672.1 million, up 8.9% reported and 6.8% organic, versus the prior-year quarter
  • Diluted EPS of $3.06 versus $2.17 a year earlier; adjusted diluted EPS of $3.48 versus $2.55
  • Free cash flow decreased 2.9% to $155.4 million, as working capital movements offset higher cash earnings
  • Share repurchases of 486,573 shares for $100.0 million; debt rose to $1.7 billion from $1.1 billion at year-end 2025
Read the filing on SEC.gov ↗
Jul 29, 4:28 PM ET

Morningstar Q2 revenue rises 9.6% to $663.2 million; diluted EPS up 35.4% to $2.83

Positive earnings Written later 2.027.01

Morningstar reported second-quarter 2026 revenue of $663.2 million, up 9.6% from the prior-year period, and diluted net income per share of $2.83, up 35.4%. Reported operating income rose 28.4% to $160.6 million, and the filing shows total debt rose to $1.7 billion as of June 30, 2026, from $1.1 billion at December 31, 2025, following the February 2026 acquisition of CRSP.

  • Revenue rose 9.6% to $663.2 million; organic revenue rose 6.8%.
  • Diluted EPS was $2.83 versus $2.09; adjusted diluted EPS rose 29.2% to $3.10.
  • Free cash flow rose 96.3% to $122.5 million; the company repurchased $100.0 million of shares in the quarter.
  • Long-term debt was $1,695.1 million at June 30, 2026, versus $1,072.6 million at December 31, 2025.
Read the filing on SEC.gov ↗
May 8, 4:23 PM ET

Morningstar elects 10 directors at annual meeting; Gail Landis does not stand for re-election

Neutral shareholder Written later 5.025.07

At its May 7, 2026 annual meeting, Morningstar shareholders elected all 10 director nominees, approved executive compensation on an advisory basis, and ratified KPMG LLP as the independent auditor for 2026. Director Gail Landis did not stand for re-election because she reached the company's mandatory retirement age, and the board size was set at 10 directors effective at the meeting's conclusion. The filing describes routine governance matters and reports no financial results.

  • Gail Landis did not stand for re-election under the director retirement policy; board size set at 10 directors
  • Bill Lyons received the lowest support among nominees: 31,265,595 votes for and 2,434,521 against
  • Executive compensation advisory vote: 32,474,755 for and 1,206,815 against
  • KPMG LLP ratified as 2026 auditor: 34,861,651 for and 89,355 against
Read the filing on SEC.gov ↗
Apr 29, 4:39 PM ET

Morningstar Q1 revenue rises 10.8% to $644.8 million; diluted EPS up 50% to $2.73

Positive earnings Written later 2.027.01

Morningstar reported first-quarter 2026 results on April 29, 2026, with revenue up 10.8% to $644.8 million and diluted net income per share up 50.0% to $2.73. Organic revenue grew 7.6%, and the CRSP acquisition closed in the quarter, which added $359.6 million in acquisition spending and raised debt to $1,712.8 million.

  • Reported revenue rose 10.8% to $644.8 million; organic revenue rose 7.6% to $617.8 million.
  • Adjusted operating income rose 31.9% to $178.6 million; adjusted diluted EPS rose 42.6% to $3.18.
  • Free cash flow fell 8.8% to $53.6 million, and the company repurchased $300.0 million of its shares.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own MORN

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $37.25M0.05% Reduced
Ray Dalio Bridgewater Associates $662.93K0.00% New

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All MORN congressional trades →
TradedMemberTypeAmount
May 06, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
May 04, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Apr 17, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Apr 16, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Feb 25, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Feb 19, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Feb 06, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000
Jan 15, 2026April McClain Delaney MD-06 · ChildSell (partial)$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Nov 05Mansueto Joseph D
Director, Executive Chairman, 10% Owner
Sell 10b5-17.25K$246.98$1.79M
Nov 04Mansueto Joseph D
Director, Executive Chairman, 10% Owner
Sell 10b5-121.40K$238.10$5.10M

Prices are end-of-day and split-adjusted. Financial data from Morningstar, Inc.'s SEC XBRL filings. Not investment advice.